• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.82% Nasdaq Up 2.46%

    Pacira Pharmaceuticals, Inc. (PCRX)

    -NasdaqGS
    56.99 Up 0.71(1.26%) Sep 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:56.28
    Open:57.27
    Bid:51.00 x 2000
    Ask:N/A
    1y Target Est:83.11
    Beta:1.89446
    Earnings Date:Oct 28 - Nov 2 (Est.)
    Day's Range:55.88 - 57.27
    52wk Range:54.00 - 121.95
    Volume:366,663
    Avg Vol (3m):677,035
    Market Cap:2.09B
    P/E (ttm):532.62
    EPS (ttm):0.11
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PCRX

    Comparison

    Symbol% ChgMkt Cap
    PCRXUp 1.26%2.09B
    ALKSUp 6.23%9.43B
    DRRXUp 0.49%249.40M

    Key Statistics

    Forward P/E (1 yr):38.51
    P/S (ttm):8.92
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.83
    Quarterly EPS Est (Sep-15) :0.15
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):0.89

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, commercializes, and manufactures proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback